Redeye provides an initial take following the release of Corline’s Q2 2025 report. As expected, this was not a quarter characterised by strong sales. The quarterly sales came in slightly below our projection, while costs were broadly in line. We will shortly publish a research update, where we anticipate making minor downward adjustments to our near-term sales estimates. That said, we do not foresee any material impact on Corline's valuation.
LÄS MER
